Science Daily: Inflammatory Biomarker Helps Identify Progressive Precancerous Lesions In The Lung C-reactive protein, a biomarker for inflammation in the blood, can help to identify individuals whose abnormal precancerous lesions will advance to closer to invasive lung cancer. C-reactive protein ... CHICAGO โ€” Stereotactic body radiation therapy (SBRT) directed at progressive lesions in patients with oligoprogressive metastatic non-small cell lung cancer (NSCLC) was beneficial and significantly ...

Context Explanation

Healio: Over 90% of hospitalized COVID-19 patients have lung lesions 2 years following discharge Over 90% of hospitalized COVID-19 patients have lung lesions 2 years following discharge As lung cancer screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians face a challenge. Most peripheral pulmonary lesions are benign, yet the ... MSN: Can tuberculosis treatment be safely shortened?

Insight Material

New studies look inside the lungs for answers Can tuberculosis treatment be safely shortened? New studies look inside the lungs for answers